Loading
Latest filing published 07 Aug 2026 for Entera Bio Ltd.. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Haya Taitel appears in our data through filings on Entera Bio Ltd. shares, published by SEC (Form 4). Between 22 August 2023 and 7 August 2026, the trades on record add up to 9 filings.
On the market, this insider has only ever bought: 4 purchases, €34k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 5 share grants. In 2026 alone, the filings show 1 purchase and no sales.
In size, the median ticket on the buying side is €8,944. On 4 out of 4 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
On 7 August 2026 came the latest disclosure, a share grant in Entera Bio Ltd. The clock since the last published purchase (11 February 2026) now reads 249 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations